968
Views
53
CrossRef citations to date
0
Altmetric
Clinical Study

Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma

, , , , &
Pages 569-573 | Received 09 Jun 2011, Accepted 12 Jul 2011, Published online: 01 Oct 2011

References

  • Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999; 125:149 - 152; PMID: 10037280
  • Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 2005; 70:343 - 356; PMID: 16869771; http://dx.doi.org/10.1101/sqb.2005.70.013
  • Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008; 13:394 - 406; PMID: 18455123; http://dx.doi.org/10.1016/j.ccr.2008.03.007
  • Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer 2001; 96:149 - 158; PMID: 11410883; http://dx.doi.org/10.1002/ijc.1013
  • Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck—a 20 years experience. Int J Oral Maxillofac Surg 2004; 33:25 - 31; PMID: 14690656; http://dx.doi.org/10.1054/ijom.2003.0448
  • Bell D, Roberts D, Kies M, Rao P, Weber RS, El-Naggar AK. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer 2010; 116:5749 - 5756; PMID: 20824717; http://dx.doi.org/10.1002/cncr.25541
  • Stenman G, Sandros J, Mark J, Edstrom S. Partial 6q deletion in a human salivary gland adenocarcinoma. Cancer Genet Cytogenet 1989; 39:153 - 156; PMID: 2752369; http://dx.doi.org/10.1016/0165-4608(89)90180-5
  • Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 2009; 106:18740 - 18744; PMID: 19841262; http://dx.doi.org/10.1073/pnas.0909114106
  • Stenman G, Andersson MK, Andren Y. New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer. Cell Cycle 2010; 9:2986 - 2995; PMID: 20647765; http://dx.doi.org/10.4161/cc.9.15.1215
  • Slamon DJ, Boone TC, Murdock DC, Keith DE, Press MF, Larson RA, et al. Studies of the human c-myb gene and its product in human acute leukemias. Science 1986; 233:347 - 351; PMID: 3014652; http://dx.doi.org/10.1126/science.3014652
  • Wilkins HR, Doucet K, Duke V, Morra A, Johnson N. Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein and decreasing transcription of the antiapoptotic protein bcl-2. Tumour Biol 2010; 31:16 - 22; PMID: 20237898; http://dx.doi.org/10.1007/s13277-009-0003-2
  • Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, et al. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability and clinicopathologic significance. Clin Cancer Res 2010; 16:4722 - 4731; PMID: 20702610; http://dx.doi.org/10.1158/1078-0432.CCR-10-0463
  • Drabsch Y, Robert RG, Gonda TJ. MYB suppresses differentiation and apoptosis of human breast cancer cells. Breast Cancer Res 2010; 12:55; PMID: 20659323; http://dx.doi.org/10.1186/bcr2614
  • Gonda TJ, Leo P, Ramsay RG. Estrogen and MYB in breast cancer: potential for new therapies. Expert Opin Biol Ther 2008; 8:713 - 717; PMID: 18476782; http://dx.doi.org/10.1517/14712598.8.6.713
  • Kim JY, Lim SJ, Park K, Lee CM, Kim J. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays. Gynecol Oncol 2005; 97:337 - 341; PMID: 15863127; http://dx.doi.org/10.1016/j.ygyno.2004.09.012
  • West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol 2011; 35:92 - 99; PMID: 21164292; http://dx.doi.org/10.1097/PAS.0b013e3182002777
  • Akrish S, Peled M, Ben-Izhak O, Nagler RM. Malignant salivary gland tumors and cyclo-oxygenase-2: a histopathological and immunohistochemical analysis with implications on histogenesis. Oral Oncol 2009; 45:1044 - 1050; PMID: 19729335; http://dx.doi.org/10.1016/j.oraloncology.2009.07.016
  • Al-Rawi NH, Omer H, Al Kawas S. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors. J Oral Pathol Med 2010; 39:48 - 55; PMID: 19761475; http://dx.doi.org/10.1111/j.1600-0714.2009.00816.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.